Germs, Hosts, and the Origin of Frank Macfarlane Burnet's Concept of "Self " and "Tolerance," 1936‑1949
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
October 24–26, 2021 2
SCIENCE · INNOVATION · POLICIES WORLD HEALTH SUMMIT BERLIN, GERMANY & DIGITAL OCTOBER 24–26, 2021 2 “No-one is safe from COVID-19; “All countries have signed up to Universal no-one is safe until we are all Health Coverage by 2030. But we cannot safe from it. Even those who wait ten years. We need health systems conquer the virus within their that work, before we face an outbreak own borders remain prisoners of something more contagious than within these borders until it is COVID-19; more deadly; or both.” conquered everywhere.” ANTÓNIO GUTERRES Secretary-General, United Nations FRANK-WALTER STEINMEIER Federal President, Germany “We firmly believe that the “All pulling together—this must rights of women and girls be the hallmark of the European are not negotiable.” Health Union. I believe this can NATALIA KANEM be a test case for true global Executive Director, United Nations Population Fund (UNFPA) health compact. The need for leadership is clear and I believe the European Union must as- sume this responsibility.” “The lesson is clear: a strong health URSULA VON DER LEYEN system is a resilient health system. Health President, European Commission systems and preparedness are not only “Governments of countries an investment in the future, they are the that are doing well during foundation of our response today.” the pandemic have not TEDROS ADHANOM GHEBREYESUS Director-General, World Health Organization (WHO) only shown political leader- ship, but also have listened “If we don’t address the concerns and to scientists and followed fears we will not do ourselves a favor. their recommendations.” In the end, it is about how technology SOUMYA SWAMINATHAN Chief Scientist, World Health can be advanced as well as how Organization (WHO) we can make healthcare more human.” BERND MONTAG President and CEO, Siemens Healthineers AG, Germany “The pandemic has brought to light the “Academic collabo ration is importance of digital technologies and in place and is really a how it can radically bridging partnership. -
Sir Charles Sherrington'sthe Integrative Action of the Nervous System: a Centenary Appreciation
doi:10.1093/brain/awm022 Brain (2007), 130, 887^894 OCCASIONAL PAPER Sir Charles Sherrington’sThe integrative action of the nervous system: a centenary appreciation Robert E. Burke Formerly Chief of the Laboratory of Neural Control, National Institute of Neurological Disorders, National Institutes of Health, Bethesda, MD, USA Present address: P.O. Box 1722, El Prado, NM 87529,USA E-mail: [email protected] In 1906 Sir Charles Sherrington published The Integrative Action of the Nervous System, which was a collection of ten lectures delivered two years before at Yale University in the United States. In this monograph Sherrington summarized two decades of painstaking experimental observations and his incisive interpretation of them. It settled the then-current debate between the ‘‘Reticular Theory’’ versus ‘‘Neuron Doctrine’’ ideas about the fundamental nature of the nervous system in mammals in favor of the latter, and it changed forever the way in which subsequent generations have viewed the organization of the central nervous system. Sherrington’s magnum opus contains basic concepts and even terminology that are now second nature to every student of the subject. This brief article reviews the historical context in which the book was written, summarizes its content, and considers its impact on Neurology and Neuroscience. Keywords: Neuron Doctrine; spinal reflexes; reflex coordination; control of movement; nervous system organization Introduction The first decade of the 20th century saw two momentous The Silliman lectures events for science. The year 1905 was Albert Einstein’s Sherrington’s 1906 monograph, published simultaneously in ‘miraculous year’ during which three of his most celebrated London, New Haven and New York, was based on a series papers in theoretical physics appeared. -
Diphtheria Serum and Serotherapy. Development, Production and Regulation in Fin De Siècle Germany
Diphtheria serum and serotherapy. Development, Production and regulation in fin de siècle Germany Axel C. Hüntelmann Institute for the History of Medicine, Ruprecht-Karls-University Heidelberg. [email protected] Dynamis Fecha de recepción: 3 de enero de 2007 [0211-9536] 2007; 27: 107-131 Fecha de aceptación: 8 de marzo de 2007 SUMMARY: 1.—Introduction. 2.—The socio-cultural context of science in fin de siècle Germany. 3.— The development of diphtheria serum in Germany. 4.—The production of diphtheria serum in the German Empire. 5.—State control of diphtheria serum. 6.—Serum networks and indirect state regulation. ABSTRACT: The development, production and state regulation of diphtheria serum is outlined against the background of industrialisation, standardization, falling standards of living and rising social conflict in fin de siècle Germany. On one hand, diphtheria serum offered a cure for an infectious disease and was a major therapeutic innovation in modern medicine. On the other hand, the new serum was a remedy of biological origin and nothing was known about its side effects or long-term impact. Moreover, serum therapy promised high profits for manufacturers who succeeded in stabilizing the production process and producing large quantities of serum in so-called industrial production plants. To minimize public health risks, a broad system of state regulation was installed, including the supervision of serum production and distribution. The case of diphtheria serum illustrates the indirect forms of government supervision and influence adopted in the German Empire and the cooperation and networking among science, state and industry. PALABRAS CLAVE: suero antidiftérico, Alemania, regulacion estatal, seroterapia, redes entre ciencia, estado e industria, Emil Behring. -
Commencement1991.Pdf (8.927Mb)
TheJohns Hopkins University Conferring of Degrees At the Close of the 1 1 5th Academic Year MAY 23, 1991 Digitized by the Internet Archive in 2012 with funding from LYRASIS Members and Sloan Foundation http://archive.org/details/commencement1991 Contents Order of Procession 1 Order of Events 2 Johns Hopkins Society of Scholars 10 Honorary Degree Citations 12 Academic Regalia 15 Awards 17 Honor Societies 21 Student Honors 23 Degree Candidates 25 As final action cannot always be taken by the time the program is printed, the lists of candidates, recipients of awards and prizes, and designees for honors are tentative only. The University reserves the right to withdraw or add names. Order ofProcession MARSHALS Sara Castro-Klaren Peter B. Petersen Eliot A. Cohen Martin R. Ramirez Bernard Guyer Trina Schroer Lynn Taylor Hebden Stella M. Shiber Franklin H. Herlong Dianne H. Tobin Jean Eichelberger Ivey James W. Wagner Joseph L. Katz Steven Yantis THE GRADUATES * MARSHALS Grace S. Brush Warner E. Love THE FACULTIES **- MARSHALS Lucien M. Brush, Jr. Stewart Hulse, Jr. THE DEANS MEMBERS OF THE SOCIETY OF SCHOLARS OFFICERS OF THE UNIVERSITY THE TRUSTEES CHDZF MARSHAL Noel R. Rose THE VICE PRESIDENT OF THE JOHNS HOPKINS UNDTERSLTY ALUMNI ASSOCIATION THE CHAPLAINS THE PRESENTERS OF THE HONORARY DEGREE CANDIDATES THE HONORARY DEGREE CANDIDATES THE INTERIM PROVOST OF THE UNIVERSITY THE CHADIMAN OF THE BOARD OF TRUSTEES THE PRESIDENT OF THE UNDTERSLTY 1 Order ofEvents William (.. Richardson President of the University, presiding * * « PRELUDE Suite from the American Brass Band Journal G.W.E. Friederich (1821-1885) Suite from Funff— stimmigte blasenda Music JohannPezel (1639-1694) » PROCESSIONAL The audience is requested to stand as the Academic Procession moves into the area and to remain standing after the Invocation. -
Metchnikoff and the Phagocytosis Theory
PERSPECTIVES TIMELINE Metchnikoff and the phagocytosis theory Alfred I. Tauber Metchnikoff’s phagocytosis theory was less century. Indeed, the clonal selection theory and an explanation of host defence than a the elucidation of the molecular biology of the proposal that might account for establishing immune response count among the great and maintaining organismal ‘harmony’. By advances in biology during our own era5. tracing the phagocyte’s various functions Metchnikoff has been assigned to the wine cel- Figure 1 | Ilya Metchnikoff, at ~45 years of through phylogeny, he recognized that eating lar of history, to be pulled out on occasion and age. This figure is reproduced from REF. 14. the tadpole’s tail and killing bacteria was the celebrated as an old hero. same fundamental process: preserving the However, to cite Metchnikoff only as a con- integrity, and, in some cases, defining the tributor to early immunology distorts his sem- launched him into the turbulent waters of evo- identity of the organism. inal contributions to a much wider domain. lutionary biology. He wrote his dissertation on He recognized that the development and func- the development of invertebrate germ layers, I first encountered the work of Ilya tion of the individual organism required an for which he shared the prestigious van Baer Metchnikoff (1845–1916; FIG. 1) in Paul de understanding of physiology in an evolution- Prize with Alexander Kovalevski. By the age of Kruif’s classic, The Microbe Hunters 1.Who ary context. The crucial precept: the organism 22 years, he was appointed to the position of would not be struck by the description of this was composed of various elements, each vying docent at the new University of Odessa, where, fiery Russian championing his theory of for dominance. -
Nobel Prize in Medicine 1952 Was Awarded to Selman A
History of Мedicine of the Newest period (XX-XXI centuries). EHRLICH AND ARSPHENAMINE Paul Ehrlich In 1910, with his colleague Sahachiro Hata, conducted tests on arsphenamine, once sold under the commercial name Salvarsan. Salvarsan, a synthetic preparation containing arsenic, is lethal to the microorganism responsible for syphilis. SULFONAMIDE DRUGS In 1932 the German bacteriologist Gerhard Domagk announced that the red dye Prontosil is active against streptococcal infections in mice and humans. Soon afterward French workers showed that its active antibacterial agent is sulfanilamide. In 1928 ALEXANDER FLEMING noticed the PENICILLIN inhibitory activity of a stray mold on a plate culture of staphylococcus bacteria. In 1938 HOWARD FLORY, ERNEST CHAIN received pure penicillin. In 1945 ALEXANDER FLEMING, HOWARD FLORY, ERNEST CHAIN won the Noble Prize for the discovery of penicillin and its curative effect in various infectious diseases. ANTITUBERCULOSIS DRUGS •In 1944, SELMAN WAXMAN announced the discovery of STREPTOMYCIN from cultures of a soil organism Streptomyces griseus, and stated that it was active against M. tuberculosis. •Clinincal trials confirmed this claim. •The Nobel Prize in Medicine 1952 was awarded to Selman A. Waksman •In Paris, Élie Metchnikoff had already detected the role of white blood cells in the IMMUNOLOGY immune reaction, •Jules Bordet had identified antibodies in the blood serum. •The mechanisms of antibody activity were used to devise diagnostic tests for a number of diseases. •In 1906 August von Wassermann gave his name to the blood test for syphilis, and in 1908 the tuberculin test— the skin test for tuberculosis— came into use. INSULIN •In 1921, Frederick Banting and Charles H. -
SCIENTIFIC REPORT 2020 for the Years 2016 to 2019 Table of Contents
SCIENTIFIC REPORT 2020 For the years 2016 to 2019 Table of Contents 3 Foreword 4 Research in Numbers 7 Strategic Vision 9 Research Pillars 10 Pillar I: Dissecting Tumour Survival Mechanisms and Tumour Microenvironment 18 Pillar II: Tracking and Targeting Minimal Residual Disease 22 Pillar III: Next Generation Molecular Imaging to Better Personalise Treatment 27 Pillar IV: Accelerating Anticancer Drug Development 33 Pillar V: Developing New Approaches to Patient Empowerment and Well-being 40 New facilities will bring new opportunities for research 41 Organisation of Research Governance Research Support Units 48 Collaborations 51 Funding Les Amis de l’Institut Bordet Research Grants 54 Visiting Medical Research Fellows (2016-2019) 55 Awards 56 Publications 2016-2019 2016-2019 (Selected Papers) Publications 2019 79 Abbreviations 2 Foreword Dominique de Valeriola General Medical Director Institut Jules Bordet is a public and academic OECI*-certified comprehensive cancer center playing an important role in cancer care, research and education, both in Belgium and internationally. Entirely dedicated to adult cancer patients since its creation in 1939, it belongs to the City of Brussels and the Université Libre de Bruxelles. Both translational and clinical research are part of the Institute’s DNA, aiming to bring research discoveries to the patient’s bedside quickly. The present 2016-2019 scientific report reflects the spirit of commitment and collaboration of the Institute’s healthcare professionals, researchers, and administrative support teams and, above all, of the patients who trust our teams and volunteer to participate in clinical trials. A concerted and well-rewarded effort has been made during these recent years to build a stronger partnership with patients in developing our clinical trials, and to establish more efficient, centralised governance and operational support for our research activities. -
Balcomk41251.Pdf (558.9Kb)
Copyright by Karen Suzanne Balcom 2005 The Dissertation Committee for Karen Suzanne Balcom Certifies that this is the approved version of the following dissertation: Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine Committee: E. Glynn Harmon, Supervisor Julie Hallmark Billie Grace Herring James D. Legler Brooke E. Sheldon Discovery and Information Use Patterns of Nobel Laureates in Physiology or Medicine by Karen Suzanne Balcom, B.A., M.L.S. Dissertation Presented to the Faculty of the Graduate School of The University of Texas at Austin in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy The University of Texas at Austin August, 2005 Dedication I dedicate this dissertation to my first teachers: my father, George Sheldon Balcom, who passed away before this task was begun, and to my mother, Marian Dyer Balcom, who passed away before it was completed. I also dedicate it to my dissertation committee members: Drs. Billie Grace Herring, Brooke Sheldon, Julie Hallmark and to my supervisor, Dr. Glynn Harmon. They were all teachers, mentors, and friends who lifted me up when I was down. Acknowledgements I would first like to thank my committee: Julie Hallmark, Billie Grace Herring, Jim Legler, M.D., Brooke E. Sheldon, and Glynn Harmon for their encouragement, patience and support during the nine years that this investigation was a work in progress. I could not have had a better committee. They are my enduring friends and I hope I prove worthy of the faith they have always showed in me. I am grateful to Dr. -
Emil Von Behring (1854–1917) the German Bacteriologist
Emil von Behring (1854–1917) The German bacteriologist and Nobel Prize winner Emil von Behring ranks among the most important medical scientists. Behring was born in Hansdorff, West Prussia, as the son of a teacher in 1854. He grew up in narrow circumstances among eleven brothers and sisters. His desire to study medicine could only be realized by fulfilling the obligation to work as an military doctor for a longer period of time. Between 1874 and 1878 he studied medicine at the Akademie für das militärärztliche Bildungswesen in Berlin. In 1890, after having published his paper Ueber das Zustandekommen der Diphtherie- Immunität und der Tetanus-Immunität bei Thieren, he captured his scientific breakthrough. While having worked as Robert Koch’s scientific assistant at the Berlin Hygienic Institute he had been able to show – together with his Japanese colleague Shibasaburo Kitasato (1852–1931) – via experimentation on animal that it was possible to neutralize pathogenic germs by giving „antitoxins“. Behring demonstrated that the antitoxic qualities of blood are not seated in cells, but in the cell-free serum. Antitoxins recovered of human convalenscents or laboratorty animals, prove themselves as life-saving when being applied to diseased humans. At last – due to Behring’s discovery of the body’s own immune defence and due to his development of serotherapy against diphtheria and tetanus – a remedy existed which was able to combat via antitoxin those infectious diseases which had already broken out. Having developped a serum therapy against diphtheria and tetanus Behring won the first Nobel Prize in Medicine in 1901. Six years before, in 1895, he had become professor of Hygienics within the Faculty of Medicine at the University of Marburg, a position he would hold for the rest of his life. -
Timeline of Immunology
TIMELINE OF IMMUNOLOGY 1549 – The earliest account of inoculation of smallpox (variolation) occurs in Wan Quan's (1499–1582) 1718 – Smallpox inoculation in Ottoman Empire realized by West. Lady Mary Wortley Montagu, the wife of the British ambassador to Constantinople, observed the positive effects of variolation on the native population and had the technique performed on her own children. 1796 – First demonstration of smallpox vaccination (Edward Jenner) 1837 – Description of the role of microbes in putrefaction and fermentation (Theodore Schwann) 1838 – Confirmation of the role of yeast in fermentation of sugar to alcohol (Charles Cagniard-Latour) 1840 – Proposal of the germ theory of disease (Jakob Henle) 1850 – Demonstration of the contagious nature of puerperal fever (childbed fever) (Ignaz Semmelweis) 1857–1870 – Confirmation of the role of microbes in fermentation (Louis Pasteur) 1862 – Phagocytosis (Ernst Haeckel) 1867 – Aseptic practice in surgery using carbolic acid (Joseph Lister) 1876 – Demonstration that microbes can cause disease-anthrax (Robert Koch) 1877 – Mast cells (Paul Ehrlich) 1878 – Confirmation and popularization of the germ theory of disease (Louis Pasteur) 1880 – 1881 -Theory that bacterial virulence could be attenuated by culture in vitro and used as vaccines. Proposed that live attenuated microbes produced immunity by depleting host of vital trace nutrients. Used to make chicken cholera and anthrax "vaccines" (Louis Pasteur) 1883 – 1905 – Cellular theory of immunity via phagocytosis by macrophages and microphages (polymorhonuclear leukocytes) (Elie Metchnikoff) 1885 – Introduction of concept of a "therapeutic vaccination". Report of a live "attenuated" vaccine for rabies (Louis Pasteur and Pierre Paul Émile Roux). 1888 – Identification of bacterial toxins (diphtheria bacillus) (Pierre Roux and Alexandre Yersin) 1888 – Bactericidal action of blood (George Nuttall) 1890 – Demonstration of antibody activity against diphtheria and tetanus toxins. -
Of Rabbits and Men: the Tale of Paul Ehrlich in Our Modern World Of
Of Rabbits and Men: The Tale of Paul Ehrlich In our modern world of chemotherapy, antibiotics and antivirals, it might come as a surprise to find that the origin of all these treatments can be traced back to rabbits; the cute and fluffy kind. To understand why, we need to go all the way back to 1882 Berlin. A talented, if aimless, young German doctor, Paul Ehrlich, had just met the great microbiologist Robert Koch. Koch was giving a lecture in which he identified the pathogen responsible for tuberculosis. Ehrlich was instantly fascinated by Koch and microbiology. Unknown to himself, he had just taken the first step on a path that would help change the way disease is tackled forever1. The late 1800’s were a time of dynamic change in the sciences. Charles Darwin had proposed his Theory of Natural Selection and Thomas Edison had given us the light bulb. Amongst the many fashionable topics of the time, some biologists were fascinated by dyes; specifically the staining of living tissue. Spending all day bent over a microscope looking at the pretty colours might not seem like worthwhile science by modern standards, but these dyes had interesting properties. Dyes displayed a high level of specificity; they would only stain certain structures and pass through others. Ehrlich noticed this and soon started to think of applications for these properties. These were times when catching a chill could kill. Many well-known individuals of the time were killed in their prime due to infectious disease. Emily Brontë died from tuberculosis2, René Descartes from pneumonia3 and Pyotr Tchaikovsky died from cholera4. -
Albert Claude, 1899-1983 with the Determined Intent to Fmd out Whatever There Was in It in Terms of Isolatable from Christian De Duve and George E
~·~-------------------------NME~W~S~AMNO~V~IE;vW~S:---------------------------- Obituary 'microsomes'. That was the beginning of a rather long side voyage that led him into the heart of the cell, not in search of a virus, but Albert Claude, 1899-1983 with the determined intent to fmd out whatever there was in it in terms of isolatable from Christian de Duve and George E. Palade particles, and to account for them in a careful quantitative manner. It was a ALBERT CLAUDE, who died in Brussels on Having failed in his first project, Claude glorious voyage during which he worked out Sunday 22 May, belonged to that small group went on to study the fate of the mouse sar his now classic cell-fractionation procedure. of truly exceptional individuals who, drawing coma S-37 when grafted in rats. The thesis Most of what we know today about the almost exclusively on their own resources and he wrote on his observations earned him a chemistry and activities of subcellular com following a vision far ahead of their time, government scholarship which he used to ponents is based on his quantitative ap opened single-handedly an entirely new field go to Berlin. There he frrst worked at the proach. Claude enjoyed isolating whatever of scientific investigation. Cancer Institute of the University, but was was isolatable: from microsomes to 'large He was born on 23 August 1899, in forced to leave prematurely after showing granules' (later recognized as mitochondria), Longlier, a hamlet of some 800 inhabitants that the bacterial theory of cancer genesis chromatin threads and zymogen granules.